Boston Scientific expects to close Axonics deal in the fourth quarter
Boston Scientific said that it expects to complete its acquisition of medical technology company Axonics in the fourth quarter of 2024. The deal has been under scrutiny by the US Federal...To view the full article, register now.
Already a subscriber? Click here to view full article